Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France

Infection, Genetics and Evolution

Volumn 12, Issue 2, 2012, Pages 496-498

  Vittecoq, Marion ^a,b   Elguero, Eric ^a   Lafferty, Kevin D ^c   Roche, Benjamin ^d   Brodeur, Jacques ^e   Gauthier Clerc, Michel ^b   Missé, Dorothée ^a   Thomas, Frédéric ^a  

^a CNRS   (France)

^b STATION BIOLOGIQUE DE LA TOUR DU VALAT   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SORBONNE UNIVERSITÉ   (France)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Encephalon tumors; Latent toxoplasmosis; Malignancy; Medical geography; Nervous system

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; MALE; NONHUMAN; PRIORITY JOURNAL; SEROPREVALENCE; SEX RATIO; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREND STUDY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS; TOXOPLASMA; TOXOPLASMOSIS;

PROTOZOA; TOXOPLASMA GONDII;

EID: 84857642202     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.01.013     Document Type: Article

References (13)

1. Berger, F., Goulet, V., Le Strat, Y., de Valk, H., Désenclos, J.C., 2007. La toxoplasmose en France chez la femme enceinte en 2003: séroprévalence et facteurs associés. Institut de veille sanitaire. Available at: (accessed 30.09.11). http://www.invs.sante.fr/publications/2007/toxoplasmose/toxoplasmose.pdf.
2. Boothroyd J.C. Toxoplasma gondii: 25years and 25 major advances for the field. Int. J. Parasitol. 2009, 39:935-946.
3. Dubey J.P. Advances in the life cycle of Toxoplasma gondii. Int. J. Parasitol. 1998, 28:1019-1024.
4. Fisher J.L., Scharwtzbaum J.A., Wrensch M., Wiemels J.L. Epidemiology of brain tumors. Neurol. Clin. 2007, 25:867-890.
5. Flegr J. Influence of latent toxoplasmosis on the phenotype of intermediate hosts. Folia Parasitologica 2010, 57:81-87.
6. GLOBOCAN (IARC) Section of Cancer Information, 2008. Available at: (accessed 30.09.11). http://globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=900.
7. Howe D.K., Sibley L.D. Toxoplasma gondiicomprises three clonal lineages: correlation of parasite genotype with human disease. J. Infect. Dis. 1995, 172:1561-1566.
8. Jones J.L., Kruszon-Moran D., Wilson M. Toxoplasma gondii infection in the United States, 1999-2000. Emerg. Infect. Dis. 2003, 9:1371-1374.
9. Sibley L.D., Khan A., Ajioka J.W., Benjamin M., Rosenthal B.M. Genetic diversity of Toxoplasma gondii in animals and Humans. Phil. Trans. R. Soc. B 2009, 364:2749-2761.
10. Studeničová C., Benčaiová G., Holková R. Seroprevalence of Toxoplasma gondii antibodies in a healthy population from Slovakia. Eur. J. Intern. Med. 2006, 17:470-473.
11. Su C., Howe D.K., Dubey J.P., Ajioka J.W., Sibley L.D. Identification of quantitative trait loci controlling acute virulence in Toxoplasma gondii. PNAS 2002, 99:10753-10758.
12. Thomas F., Lafferty K.D., Brodeur J., Elguero E., Gauthier-Clerc M., Missé D. Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common. Biol. Lett. 2012, 8:101-103.
13. Wrensch M., Minn Y., Chew T., Bondy M., Berger M.S. Epidemiology of primary brain tumors: current concepts end review of the literature. Neurol. Oncol. 2002, 4:278-299.